R3 Vascular Appoints Josh Smale as its Vice President of Global Clinical and Scientific Affairs
09 juil. 2024 14h25 HE
|
R3 Vascular
R3 Vascular Inc. is pleased to announce the appointment of Josh Smale as its Vice President of Global Clinical and Scientific Affairs.
R3 Vascular Announces $87 Million in Series B Financing and Appoints Christopher M. Owens as new President and CEO
09 mai 2024 12h00 HE
|
R3 Vascular
R3 Vascular, Inc. announced the closing of its $87 million Series B financing round and the appointment of a new President and Chief Executive Officer